The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement

NCT05023278 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Pain
Chronic Pain
Knee Pain Chronic
Neuropathic Pain

Interventions

DRUG: Venlafaxine 37.5 MG
DRUG: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]